Provided by Tiger Fintech (Singapore) Pte. Ltd.

MRBL Enhanced Equity ETF

38.55
-0.2865-0.74%
Post-market: 38.550.00000.00%16:25 EDT
Volume:129.00
Turnover:4.97K
Market Cap:1.21B
PE:- -
High:38.55
Open:38.55
Low:38.55
Close:38.83
Loading ...

Company Profile

Company Name:
MRBL Enhanced Equity ETF
Exchange:
CBOE
Establishment Date:
- -
Employees:
- -
Office Location:
19 East Eagle Road,Havertown,Pennsylvania,United States
Zip Code:
19083
Fax:
216 245 3686
Introduction:
Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.